Abstract
Bcl-2 family genes are frequently amplified in small cell lung cancer (SCLC). A phase I trial was conducted to evaluate the safety of obatoclax, a Bcl-2 family inhibitor, given in combination with standard chemotherapy. Eligible patients (3-6 per cohort) had extensive-stage SCLC, measurable disease, ≤ 1 before therapy, Eastern Cooperative Oncology Group performance status 0 or 1, and adequate organ function. Patients were treated with escalating doses of obatoclax, either as a 3- or 24-h infusion, on days 1-3 of a 21-day cycle, in combination with carboplatin (area under the curve 5, day 1 only) and etoposide (100 mg m(-2), days 1-3). The primary endpoint was to determine the maximum tolerated dose of obatoclax. Twenty-five patients (56% male; median age 66 years) were enrolled in three dose cohorts for each schedule. Maximum tolerated dose was established with the 3-h infusion at 30 mg per day and was not reached with the 24-h infusion. Compared with the 24-h cohorts, the 3-h cohorts had higher incidence of central nervous system (CNS) adverse events (AEs); dose-limiting toxicities were somnolence, euphoria, and disorientation. These CNS AEs were transient, resolving shortly after the end of infusion, and without sequelae. The...Continue Reading
References
Oct 1, 1995·The Journal of Pathology·S X JiangT Kameya
Feb 3, 2000·Journal of the National Cancer Institute·P TherasseS G Gwyther
Jan 23, 2004·The New England Journal of Medicine·Alexander Spira, David S Ettinger
Jun 17, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N ThatcherP Lorigan
Sep 30, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ramaswamy GovindanJay Piccirillo
Jan 6, 2007·Cell Death and Differentiation·H ZhangC Tse
Aug 19, 2007·The New England Journal of Medicine·Ben SlotmanUNKNOWN EORTC Radiation Oncology Group and Lung Cancer Group
Nov 28, 2007·Proceedings of the National Academy of Sciences of the United States of America·Mai NguyenGordon C Shore
Dec 28, 2007·Journal of Neurophysiology·John A HickmanElizabeth A Jonas
Mar 14, 2008·Current Molecular Medicine·Matthew R Warr, Gordon C Shore
Jun 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alex R ShoemakerSteven W Elmore
Oct 22, 2008·Blood·Susan M O'BrienBruce D Cheson
Dec 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Aaron D SchimmerGautam Borthakur
Apr 8, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Primo N LaraDavid R Gandara
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark A SocinskiNick Thatcher
Feb 18, 2010·Cancer Research·Rory L SmootGregory J Gores
Feb 19, 2010·Nature·Rameen BeroukhimMatthew Meyerson
Jun 12, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jimmy J HwangJohn L Marshall
Feb 2, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leena GandhiCharles M Rudin
Apr 8, 2011·Neoplasia : an International Journal for Oncology Research·Emma J DeanCaroline Dive
Citations
Jul 2, 2014·PloS One·Dennie T FrederickRyan J Sullivan
Oct 18, 2014·Carcinogenesis·Jung-Chen SuChung-Wai Shiau
Feb 5, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Alyse N DouglassAlexis Kaushansky
Sep 13, 2013·Cancer Biology & Therapy·Nichola CruickshanksPaul Dent
Jan 22, 2013·Communicative & Integrative Biology·Qiang Liu, Hong-Gang Wang
Dec 7, 2016·Expert Opinion on Investigational Drugs·Deepa S SubramaniamGiuseppe Giaccone
Jan 7, 2015·Biochemical Pharmacology·Flavia RadognaMarc Diederich
Dec 19, 2016·F1000Research·Haiming DaiScott H Kaufmann
Jan 27, 2015·Archives of Toxicology·Waseem Ahmad SiddiquiHaseeb Ahsan
Feb 25, 2014·Applied Microbiology and Biotechnology·Nada StankovicJasmina Nikodinovic-Runic
Oct 15, 2013·British Journal of Pharmacology·M J RoyG Lessene
Dec 12, 2013·Cancer·Arya AminiRitsuko U Komaki
Mar 10, 2015·Oncotarget·Frédéric R SanterZoran Culig
Jan 1, 2014·Advances in Medicine·Meike Vogler
Jan 15, 2019·Applied Microbiology and Biotechnology·Chee-Hoo YipSheila Nathan
Jan 9, 2015·Genes & Cancer·Lotte M E Berghauser PontSieger Leenstra
Aug 22, 2015·The FEBS Journal·Joseph T Opferman
Apr 17, 2013·International Journal of Oncology·Man ZouShiying Yu
Feb 12, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Peter S KimBenedetto Farsaci
May 27, 2015·Oncotarget·Georg Karpel-MasslerMarkus D Siegelin
May 17, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert KindersRalph E Parchment
Nov 4, 2020·Acta Pharmacologica Sinica·Yan-Ping YinWen-Chu Lin
Mar 7, 2021·Viruses·Finny S VargheseRonald P van Rij
May 12, 2021·Translational Oncology·Jingye LiZhibing Li